NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking

TitleNPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking
Publication TypeJournal Article
Year of Publication2015
AuthorsPleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM, Olson DP, Lowell BB, Grant KA, Thiele TE, Kash TL
JournalNat Neurosci
Volume18
Issue4
Pagination545-52
Date Published2015 Apr
ISSN1546-1726
KeywordsAnimals, Behavior, Animal, Binge Drinking, Circadian Rhythm, Corticotropin-Releasing Hormone, Disease Models, Animal, Macaca mulatta, Male, Mice, Mice, Inbred C57BL, Neural Inhibition, Neuropeptide Y, Receptors, Neuropeptide Y, Septal Nuclei, Signal Transduction
Abstract

Binge alcohol drinking is a tremendous public health problem because it leads to the development of numerous pathologies, including alcohol abuse and anxiety. It is thought to do so by hijacking brain systems that regulate stress and reward, including neuropeptide Y (NPY) and corticotropin-releasing factor (CRF). The central actions of NPY and CRF have opposing functions in the regulation of emotional and reward-seeking behaviors; thus, dysfunctional interactions between these peptidergic systems could be involved in the development of these pathologies. We used converging physiological, pharmacological and chemogenetic approaches to identify a precise neural mechanism in the bed nucleus of the stria terminalis (BNST), a limbic brain region involved in pathological reward and anxiety behaviors, underlying the interactions between NPY and CRF in the regulation of binge alcohol drinking in both mice and monkeys. We found that NPY Y1 receptor (Y1R) activation in the BNST suppressed binge alcohol drinking by enhancing inhibitory synaptic transmission specifically in CRF neurons via a previously unknown Gi-mediated, PKA-dependent postsynaptic mechanism. Furthermore, chronic alcohol drinking led to persistent alterations in Y1R function in the BNST of both mice and monkeys, highlighting the enduring, conserved nature of this effect across mammalian species. Together, these data provide both a cellular locus and signaling framework for the development of new therapeutics for treatment of neuropsychiatric diseases, including alcohol use disorders.

DOI10.1038/nn.3972
Alternate JournalNat Neurosci
PubMed ID25751534
PubMed Central IDPMC4376619
Grant ListAA109431 / AA / NIAAA NIH HHS / United States
AA020911 / AA / NIAAA NIH HHS / United States
P30 DK046200 / DK / NIDDK NIH HHS / United States
K08 DK071561 / DK / NIDDK NIH HHS / United States
AA013541 / AA / NIAAA NIH HHS / United States
AA013573 / AA / NIAAA NIH HHS / United States
P30 NS045892 / NS / NINDS NIH HHS / United States
AA019454 / AA / NIAAA NIH HHS / United States
R01 DK096010 / DK / NIDDK NIH HHS / United States
AA022048 / AA / NIAAA NIH HHS / United States
T32 GM008322 / GM / NIGMS NIH HHS / United States
R01 DK075632 / DK / NIDDK NIH HHS / United States
R01 DK089044 / DK / NIDDK NIH HHS / United States
AA011605 / AA / NIAAA NIH HHS / United States
F32 AA021043 / AA / NIAAA NIH HHS / United States
AA021043 / AA / NIAAA NIH HHS / United States
DK057521 / DK / NIDDK NIH HHS / United States
DK075632 / DK / NIDDK NIH HHS / United States
P30 DK020572 / DK / NIDDK NIH HHS / United States
DK046200 / DK / NIDDK NIH HHS / United States
P30 DK057521 / DK / NIDDK NIH HHS / United States
R01 AA019454 / AA / NIAAA NIH HHS / United States
P50 AA011605 / AA / NIAAA NIH HHS / United States
T32 DA007244 / DA / NIDA NIH HHS / United States
U01 AA020911 / AA / NIAAA NIH HHS / United States
R37 AA013573 / AA / NIAAA NIH HHS / United States
DK071561 / DK / NIDDK NIH HHS / United States
DK096010 / DK / NIDDK NIH HHS / United States
R01 AA013573 / AA / NIAAA NIH HHS / United States
P60 AA011605 / AA / NIAAA NIH HHS / United States
R01 AA022048 / AA / NIAAA NIH HHS / United States